March 25, 2012 Critical Path Institute Announces New Board Members Critical Path Institute (C-Path) is proud to welcome four new board members who were recently elected to serve three-year terms (2
March 20, 2012 Critical Path Institute Honors World Tuberculosis Day 2012 Tuberculosis (TB) is often thought to be a disease of the past. The reality: Because no new therapies for TB have been developed i
March 6, 2012 Could Genetics Improve Warfarin Dosing? In a large-scale study and an upcoming clinical trial, scientists supported by the National Institutes of Health address one of th
February 1, 2012 Critical Path Institute Announces New CEO Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chi
January 24, 2012 European Medicines Agency Deems Imaging Biomarker a Qualified Measure to Select Patients with Early Stages of Cognitive Impairment for Alzheimer’s Disease Clinical Trials Based on a request for regulatory review by Critical Path Institute’s (C-Path) Coalition Against Major Diseases (CAMD), the
January 12, 2012 Recommendations For Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research In Adult Oncology
January 10, 2012 Combining Patient-level And Summary-level Data For Alzheimer’s Disease Modeling And Simulation: A Β Regression Meta-analysis
